Thomas Forte

Guy Riegel

- **ReposiTrak reported strong fiscal year 2025 results**, with **total revenue increasing 11% to $22.6 million** and **GAAP net income rising 17% to $7 million**.  **[50471_2161294_1]**  For the fourth quarter of fiscal 2025, **total revenue grew 11% to $5.8 million** and **diluted EPS was $0.09**.  **[50471_2161294_1]** **[50471_2161294_2]** 
- The company ended fiscal year 2025 with a **strong balance sheet**, holding **$28.6 million in cash** and **zero bank debt** as of June 30, 2025.  **[50471_2161294_1]** **[50471_2161294_2]** **[50471_2161294_3]** 
- ReposiTrak actively returned capital to shareholders, having **redeemed $5.4 million in preferred shares**, **bought back $13 million in common stock**, and **increased its common stock dividend three times by 10%** since December 2023.  **[50471_2161294_3]** 
- Strategically, the company is expanding its addressable market by leveraging automation to effectively serve **smaller accounts** and is exploring **accretive M&A opportunities**.  **[50471_2161294_4]** **[50471_2161294_8]**

ReposiTrak (TRAK)